Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - SHORT-TERM DEBT
Short-term Debt OCX - OncoCyte Corporation
665 K
LAST VALUE
-52.53%
2 YEAR CAGR
-15.79%
5 YEAR CAGR
-13.88%
10 YEAR CAGR